Pieris Pharmaceuticals to Present at the 28th Annual ROTH

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pieris Pharmaceuticals to Present at the 28th Annual ROTH Conference on March 15th at 10:30 am PDT

BOSTON, MA --(Marketwired - February 29, 2016) -   Pieris Pharmaceuticals, Inc . ( NASDAQ : PIRS ), a biotechnology company advancing its proprietary Anticalin ® bio therapeutic technologies, announced today that CEO Stephen Yoder will present a corporate overview of the Company and meet with investors at the 28 th Annual ROTH Conference. The conference will take place on March 13-16, 2016 at the Ritz Carlton in Dana Point, California.

Mr. Yoder is scheduled to present on Tuesday, March 15 th at 10:30 am PDT. The presentation will be webcast live and available for replay at: http://wsw.com/webcast/roth30/pirs and on the investor relations section of the Company's website at www.pieris.com .

Accredited investors are also invited to request a one-on-one meeting with Pieris Pharmaceuticals management during the conference by contacting their ROTH representative at (800) 933-6830 or email conference@roth.com .

About Pieris Pharmaceuticals:

Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalins are a novel class of protein therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Anticalin ® , Anticalins ® are registered trademarks of Pieris. For more information visit  www.pieris.com .

Forward Looking Statements:

This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to novel technologies and methods; our business and product development plans; our liquidity and ability to fund our future operations; our ability to achieve certain milestones and receive future milestone or royalty payments; or market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, our ability to raise the additional funding we will need to continue to pursue our business and product development plans; the inherent uncertainties associated with developing new products or technologies and operating as a development stage company; our ability to develop, complete clinical trials for, obtain approvals for and commercialize any of our product candidates; competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents we file with the SEC available at www.sec.gov , including without limitation the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and the Company's Quarterly Reports on Form 10-Q.

Company Contact:   Pieris Pharmaceuticals, Inc.  Darlene Deptula-Hicks  SVP & Chief Financial Officer  +1-603-553-5803  deptula@pieris.com   Investor Relations Contact: The Trout Group Thomas Hoffmann +1-646-378-2931 thoffmann@troutgroup.com or Media Inquiries: Gretchen Schweitzer  +49 172 861 8540  gschweitzer@macbiocom.com   The Del Mar Consulting Group, Inc. Robert Prag President +1-858-794-5000 bprag@delmarconsulting.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 75

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
Premier Energy's €850M Debt Bet on Evryo Nears Close

Updated Category News Views 117

A Bridge Loan Gives Way to a Real Commitment Eight hundred and fifty million euros is not the sort of number a company tosses around for decoration. Premier Energy has secured a five-year senior facilities agreement to fund its planned acquisition of Evryo Group, including electricity distribution subsidiary Distribu?ie Energie Oltenia S.A., and to refinance roughly...

Continue Reading
Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 118

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners

Updated Category News Views 174

Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...

Continue Reading
Telit Cinterion Tests Its Defense Connectivity Pitch

Updated Category News Views 107

Defense connectivity is a messy business, and Telit Cinterion is leaning straight into the mess at NATO Edge 2026 in Izmir, Turkey. From November 17 through 19, the company is using Booth L86 to show how several wireless links can live inside one mission-focused setup. That may sound like standard trade-show wallpaper, but the underlying problem is very real: military and...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 194

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Ivanti's AI Push Rests on Data, Control and Results

Updated Category News Views 216

Enterprise AI has a nasty habit of sounding brilliant right up until it meets a messy fleet of laptops, phones, patches and permissions. Ivanti’s latest product push is aimed squarely at that unglamorous collision point: giving AI systems governed access to the operational data inside Ivanti Neurons, then keeping humans and pre-set permissions in charge of what happens...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 158

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 148

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading

Top 5 Most Recently Viewed Articles

Survey Reveals Enterprises Unready for Rising AI Power Needs

Updated Category News Views 257

Understanding the Readiness Gap in AI Power Demand Recent research sheds light on a concerning trend among enterprises regarding their preparedness to meet the escalating power demands posed by artificial intelligence (AI). Conducted by SambaNova, this survey demonstrates that while many leaders acknowledge the urgent need for energy management in AI, only a fraction...

Continue Reading
Ellevio Reports Solid Gains in H1 Despite Cash Flow Dip

Updated Category News Views 47

In a world where the electricity flows must keep pace with surging demands and regulatory labyrinths, Ellevio AB is not just hanging in there; it's pushing forward with gusto. They've just released their Half-year Report for 2026, and the numbers show a steady pulse amidst the evolving Swedish energy market conditions. With key stakeholders like OMERS Infrastructure and...

Continue Reading
Dan Orlando Releases Captivating New Music Video for Fans

Updated Category News Views 219

Dan Orlando's Artistic Journey Shines in New Video Musician Dan Orlando has just released his newest music video, 'Music In My Head.' This marks an important step in his artistic journey, showcasing his growth and dedication to producing music that resonates across various styles. A Heartfelt Connection with His Audience The video for 'Music In My Head' highlights...

Continue Reading
Revolutionizing API Testing with Parasoft's Agentic AI

Updated Category News Views 513

Parasoft Enhances API Testing with Agentic AI Parasoft, a global leader in AI-driven software testing solutions, has unveiled its latest innovation: the Agentic AI approach. This groundbreaking feature aims to transform API testing, making it more efficient and effective for software development teams. By integrating intelligent, outcome-based scenario testing, Parasoft...

Continue Reading
PPL Corporation's Growth Continues: Q1 Insights Unpacked

Updated Category News Views 193

PPL Corporation Reports Impressive First Quarter Earnings PPL Corporation (NYSE: PPL) has posted remarkable financial results for the first quarter, demonstrating solid performance and strategic execution. The company's reported earnings per share (EPS) for the quarter stands at $0.56, a significant increase compared to $0.42 in the previous year. Notably, ongoing...

Continue Reading